United Therapeutics Corporation Stock Price and Value Analysis

Should you buy United Therapeutics Corporation stock? (NasdaqGS:UTHR). Let's see how it does in our automated value investing analysis system.

  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This company pays no dividend.

UTHR Free Cash Flow Trend

Based on historical returns, we believe that United Therapeutics Corporation can grow its free cash at a rate of about 4%. That's positive!

Free Cash Flow trendline for UTHR
Free Cash Flow trendline for United Therapeutics Corporation

Inside the UTHR Numbers

UTHR Price
(United Therapeutics Corporation stock price per share)
[?] UTHR Fair Price
(based on intrinsic value)
[?] UTHR Safety Price (based on a variable margin of safety) $63.57
[?] PE Ratio versus Sector 45% lower than other Healthcare stocks
[?] PE Ratio versus Industry 61% lower than other Drug Manufacturers - Other stocks
[?] Cash Yield 0.96%
[?] Free Cash Flow Jitter 0%

Is United Therapeutics Corporation Stock on Sale?

We believe that United Therapeutics Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

United Therapeutics Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy UTHR Stock?

Does United Therapeutics Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Stockalyzer::Template::Plugin::Bootstrap=HASH(0x7a9e850) 8